In short, RPS27A, RPLP0 and ETF1 may be the potential target gene for the treatment of MSCs in DN, which provide a theoretical basis for the investigation of MSCs in the treatment of DN. The gene discussed is ETF1; the disease is liver dysplastic nodule.